Ganga Pharmaceuticals share news and announcements

BSE: 539680Pharmaceuticals & Biotechnology

Last traded ₹12.50 on 8 Sep 2026

Ganga Pharmaceuticals board and management

17 filed, newest first.

Sep 2026
- 26 Sep · Management
  Re-appointment of Managing Director (opens in a new tab)
May 2026
- 21 May · Management
  Appointment of Secretarial Auditor (opens in a new tab)
- 21 May · Management
  Appointment of Internal Auditor (opens in a new tab)
Mar 2026
- 10 Mar · Management
  Re-appointment of Mr. Bharat Brijmohan Sharma as Managing Director of the Company for a further period of Three year effective from April 01, 2026 (opens in a new tab)
- 10 Mar · Management
  Re-appointment of Mr. Bharat Brijmohan Sharma as Managing Director for a further period of Three years effective from April 01, 2026 (opens in a new tab)
Aug 2025
- 20 Aug · Management
  Appointment of Statutory Auditor (opens in a new tab)
Jul 2025
- 1 Jul · Management
  Appointment of the Company Secretary and Compliance Officer of the Company (opens in a new tab)
Apr 2025
- 22 Apr · Management
  Resignation of Company Secretary and Compliance Officer (opens in a new tab)
Mar 2025
- 31 Mar · Management
  Cessation of Directorship of Mr. Chetan Bhikubhai Patel and Mr. Sachin Chandrakant Chavan due to completion of tenure (opens in a new tab)
- 31 Mar · Management
  Cessation of Directorship of Mr. Chetan Bhikubhai Patel and Sachin Chandrakant Chavan due to completion of tenure (opens in a new tab)
- 27 Mar · Management
  Appointment of Independent Directors (opens in a new tab)
Aug 2022
- 22 Aug · Management
  Intimation under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Appointment of Statutory Auditors (opens in a new tab)
May 2020
- 25 May · Management
  This is to inform you that the Board of Directors vides its circular resolution dated May 25, 2020: Considered and took note of the resignation of Mr. Sanjay V. Kulkarni and .... (opens in a new tab)
- 23 May · Management
  With reference to the captioned subject and pursuant to the regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that Mr. Sanjay .... (opens in a new tab)
Feb 2020
- 27 Feb · Management
  With reference to the captioned subject and in compliance with the regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform you that .... (opens in a new tab)
Aug 2018
- 30 Aug · Management
  This is to inform you that Mr. Ganesh Jyothimani Paradeshi, Chief Financial Officer (CFO) of the Company has resigned with effect from August 30, 2018. We request you to kindly .... (opens in a new tab)
Mar 2016
- 22 Mar · Management
  Ms. Priti Kothari Bhaiya, has been appointed as Company Secretary and Compliance Officer of the Company as required in terms of the provisions ....